Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3430)
All Articles published online
|
Nov 15, 2003 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Luo JY, Niu CY, Wang XQ, Zhu YL, Gong J. Effect of a single oral dose of rabeprazole on nocturnal acid breakthrough and nocturnal alkaline amplitude. World J Gastroenterol 2003; 9(11): 2583-2586 [PMID: 14606102 DOI: 10.3748/wjg.v9.i11.2583] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i11/2583.htm |
| Number | Citing Articles |
| 1 |
Itzhel García-Torres, Ignacio de la Mora-de la Mora, Jaime Marcial-Quino, Saúl Gómez-Manzo, América Vanoye-Carlo, Gabriel Navarrete-Vázquez, Blanca Colín-Lozano, Pedro Gutiérrez-Castrellón, Edgar Sierra-Palacios, Gabriel López-Velázquez, Sergio Enríquez-Flores. Proton pump inhibitors drastically modify triosephosphate isomerase from Giardia lamblia at functional and structural levels, providing molecular leads in the design of new antigiardiasic drugs. Biochimica et Biophysica Acta (BBA) - General Subjects 2016; 1860(1): 97 doi: 10.1016/j.bbagen.2015.10.021
|
| 2 |
PWY LIM, KL GOH. Review Article: Efficacy and safety of rabeprazole in treating gastroesophageal reflux disease. Journal of Gastroenterology and Hepatology 2004; 19(s3) doi: 10.1111/j.1440-1746.2004.03592.x
|
| 3 |
Atieh Yaghoubi, Saeid Amel Jamehdar, Mohammad Reza Akbari Eidgahi, Kiarash Ghazvini. Evaluation of the therapeutic effect of melittin peptide on the ulcerative colitis mouse model. International Immunopharmacology 2022; 108: 108810 doi: 10.1016/j.intimp.2022.108810
|
| 4 |
Farwa Jafri, Zachary L. Taylor, Daniel Gonzalez, Valentina Shakhnovich. Effects of obesity on the pharmacology of proton pump inhibitors: current understanding and future implications for patient care and research. Expert Opinion on Drug Metabolism & Toxicology 2023; 19(1): 1 doi: 10.1080/17425255.2023.2178897
|
| 5 |
Nirmala Ganesan, N. Anandhabhairavi, S. Arivarasan, V. Balamurugan, T. Anitha. Astragalin Nanoparticles Ameliorates CCl4 - Induced Liver Fibrosis in Rats. Biomedical and Pharmacology Journal 2024; 17(2): 757 doi: 10.13005/bpj/2902
|
| 6 |
Kafia Belhocine, Fabienne Vavasseur, Christelle Volteau, Laurent Flet, Yann Touchefeu, Stanislas Bruley des Varannes. Controlling on-demand gastric acidity in obese subjects: a randomized, controlled trial comparing a single dose of 20 mg rabeprazole and 20 mg omeprazole. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-128
|
| 7 |
Stefano Pallotta, Fabio Pace, Silvia Marelli. Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease. Expert Review of Gastroenterology & Hepatology 2008; 2(4): 509 doi: 10.1586/17474124.2.4.509
|
| 8 |
Alice Miriam Kitay, Marie-Therese Schneebacher, Anne Schmitt, Katharina Heschl, Sascha Kopic, Tariq Alfadda, Abrar Alsaihati, Alexander Link, John Peter Geibel. Modulations in extracellular calcium lead to H+-ATPase-dependent acid secretion: a clarification of PPI failure. American Journal of Physiology-Gastrointestinal and Liver Physiology 2018; 315(1): G36 doi: 10.1152/ajpgi.00132.2017
|
| 9 |
Tayebe Shahbazi, Bita Bakhshi, Mohammad Sadegh Fazeli, Elahe Derakhshan-Nezhadc. Bacterial biomarkers: new aspects of colorectal tumors diagnosis: reality or fantasy. European Journal of Cancer Prevention 2023; 32(5): 485 doi: 10.1097/CEJ.0000000000000760
|
| 10 |
Hank S. Wang, David S. Oh, Ariana Anderson, Jose Nieto, Phuong Tien, Gordon Ohning, Joseph R. Pisegna. Comparative Efficacy of Rabeprazole and Pantoprazole in the Control of Nocturnal Acid Output and Intragastric Acidity. Gut and Liver 2008; 2(1): 30 doi: 10.5009/gnl.2008.2.1.30
|
| 11 |
P. MINER, B. DELEMOS, J. XIANG, J. LOCOCO, J. IENI. Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24‐h intragastric acidity and oesophageal acid exposure: a randomized study in gastro‐oesophageal reflux disease patients with a history of nocturnal heartburn. Alimentary Pharmacology & Therapeutics 2010; 31(9): 991 doi: 10.1111/j.1365-2036.2010.04255.x
|
| 12 |
S. WARRINGTON, K. BAISLEY, D. LEE, K. LOMAX, B. DELEMOS, M. BOYCE, A. MOROCUTTI. Pharmacodynamic effects of single doses of rabeprazole 20 mg and pantoprazole 40 mg in patients with GERD and nocturnal heartburn. Alimentary Pharmacology & Therapeutics 2007; 25(4): 511 doi: 10.1111/j.1365-2036.2006.03196.x
|